Pharma


 Faron Pharma's Candidate Earns FDA Fast Track

Faron Pharma's Candidate Earns FDA Fast Track

August 27, 2024 09:00 AM AEST| By Team Kalkine Media

Faron Pharmaceuticals,(LSE:FARN),, a clinical-stage biopharmaceutical company, announced on Tuesday that its lead candidate, bexmarilimab, has received fast track designation from the US Food and Drug Administration (FDA). This designation applies to...

 Faron Pharmaceuticals to Expand Bexmarilimab Development Under New CMO

Faron Pharmaceuticals to Expand Bexmarilimab Development Under New CMO

August 06, 2024 08:25 PM AEST| By Team Kalkine Media

On August 6, 2024, Faron Pharmaceuticals Ltd. (LSE: FARN), a clinical-stage biopharmaceutical firm focused on innovative cancer therapies, announced the appointment of Dr. Petri Bono as its new Chief Medical Officer (CMO). Dr. Bono will officially be...

 Destiny Pharma Shares Decline Despite Positive XF-73 MRSA Data

Destiny Pharma Shares Decline Despite Positive XF-73 MRSA Data

August 05, 2024 09:53 PM AEST| By Team Kalkine Media

XF-73 Data Announced,Destiny Pharma PLC announced promising results for its lead drug, exeporfinium chloride, branded as XF-73, on Monday. The Brighton-based clinical-stage biotechnology company revealed data from a recent study indicating that XF-73...

AI on the Rise: A Look at Top AI Companies and Their Stocks

Send OTP Resend OTP in 30s
Verify OTP

Recent Articles






Investing Tips

Previous Next